Friday, 16 April, 2021

United Kingdom reports more clotting cases in people receiving the AstraZeneca shot

Australia investigates possible link of blood clot case to vaccine The Netherlands suspends use of AstraZeneca vaccine for under-60s
Deanna Wagner | 03 April, 2021, 23:57

British regulators have identified 30 cases of rare blood clots after the use of the AstraZeneca Covid-19 vaccine, 25 more than the agency previously reported, after millions of doses were administered.

It is still unknown if the clots are a side effect of the vaccine or merely a coincidence but the MHRA stress the benefits continue to outweigh any risk.

The Medicines and Healthcare Regulatory Agency said the risk associated with this type of blood clot is "very small" and that the public should continue to take up the vaccine when offered it.

The Netherlands Friday suspended use of the Oxford/AstraZenca vaccine for people under the age of 60, citing concern about an increased risk of blood clots.

Speaking to the BBC's Good Morning Scotland radio programme, Professor Linda Bauld of Edinburgh University said reports of blood clots were "very rare" and a direct link to the vaccine was very unlikely.

The agency said late Friday the cases relate to the period up to March 24, during which 18.1 million doses of the vaccine had been administered and that it hadn't received any similar reports with regard to the Pfizer-BioNTech vaccine.

Police officer killed in vehicle attack on US Capitol
The US Capitol complex was placed on lockdown after the shooting, and staffers were told they could not enter or exit buildings. But CBS News reported that security officials had already warned congressional staffers of a threat before the auto ramming.

This comes after countries across Europe halted the use of the AstraZeneca jab for certain groups.

"There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks", Canada's National Advisory Committee on Immunization said.

Noor Azmi said besides the annual programme, the less fortunate students also received the Parent-Teacher Association fee payment and school supplies assistance to reduce their burden due to the spread of the Covid-19 pandemic.

The EMA regards the vaccine - which has been given to millions of people - as safe and effective, and is expected to announce updated advice about the jab next Wednesday.

It is not clear whether the illness is linked to the man's vaccination in Victoria, but health authorities are taking it seriously, Acting Chief Medical Officer Michael Kidd says.

Last week, Britain announced a third coronavirus vaccine from U.S. firm Moderna (MRNA) will be rolled out in the United Kingdom from April and will join the AstraZeneca and Pfizer (PFE)/ BioNtech (BNTX) jabs already being offered on the NHS.